HempFusion(R), a leading dietary supplements company focused on products that contain Hemp/CBD in the United States with distribution of its family of brands to approximately 4,000 retailers across 47 states, today announced the sponsorship and participation in ValidCare’s scientific study that addresses the Food and Drug Administration’s (“FDA”) previous questions about CBD products. According to the update, ValidCare will be conducting a human trial and study to determine if daily use of full-spectrum hemp-derived CBD or CBD isolate has any impact on the human liver. HempFusion is one of ten select CBD companies sponsoring and participating in the ground-breaking study. “We are incredibly proud to participate in ValidCare’s study and help advance scientific research surrounding CBD” HempFusion Co-CEO Jason Mitchell, N.D. stated in the news release. “As a Company, we are built on a foundation of regulatory compliance as well as consumer safety and participation in this study helps establish HempFusion as a leader in the global CBD industry.”
To view the full press release, visit http://cnw.fm/DYB1r
About HempFusion
HempFusion is a premium wellness company featuring dietary supplements including hemp-based cannabidiol (“CBD”) with distribution of its family of brands to approximately 4,000 retailers across 47 US states. The Company strives to maintain the highest level of compliance in the industry. HempFusion’s wide variety of 25+ CBD products with a full spectrum of cannabinoids and other constituents are sourced from quality phytocompounds manufactured under cGMP standards designed to attain efficacy and safety. HempFusion’s primary focus is formulating and marketing premium consumer-specific product lines with various delivery methods, across multiple distribution platforms. The Company’s CBD products are based on a proprietary Whole Food Panoramic Full-Spectrum Hemp Complex(TM) and are available through independently owned and national chain health food stores, or by visiting www.HempFusion.com.
About HempWire
HempWire (HW) is a dedicated information provider focused on (1) aggregating hemp-related news, (2) issuing HempNewsBreaks designed to update investors on the latest developments in the hemp market, (3) enhancing corporate news releases, (4) providing full-service distribution and social media offerings to public and private client-partners and (5) designing and implementing all-inclusive corporate communication solutions. HW is strategically positioned within the rapidly expanding hemp sector with a team of journalists working to help a growing roster of public and private companies reach a wide audience of investors, consumers and members of the media. We leverage a vast network of more than 5,000 key syndication outlets to deliver unparalleled visibility, recognition and content to the hemp industry. HempWire (HW) is where HEMP news, content and information converge.
To receive instant SMS alerts, text HEMPWIRE to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.hempwire.com
Please see full terms of use and disclaimers on the HempWire website applicable to all content provided by HW, wherever published or re-published: https://www.hempwire.com/Disclaimer
Do you have questions or are you interested in working with HW? Ask our Editor
HempWire (HW)
Denver, Colorado
www.hempwire.com
303.498.7722 Office
Editor@HempWire.net
HempWire is part of the InvestorBrandNetwork.
